文献速递心外重症与机械循环支持先天性心脏病外科

新生儿严重先天性膈疝ECMO支持26年单中心经验

The use of extracorporeal membrane oxygenation in neonates with severe congenital diaphragmatic hernia: a 26-year experience from a tertiary centre.
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

该研究回顾性分析1989至2015年98例因严重先天性膈疝需ECMO支持的新生儿,院内死亡率为32%,总死亡率47.9%。术前、术中或术后使用ECMO对生存无显著影响;需血液滤过或出现神经系统并发症与生存率降低显著相关。作者认为临床指征明确时应为所有严重膈疝新生儿提供ECMO选项。

要点

  • 严重先天性膈疝新生儿ECMO支持院内死亡率32%,总死亡率47.9%。
  • 术前、术中或术后ECMO支持的生存率无显著差异。
  • 需血液滤过或神经系统并发症与生存率降低显著相关。

核心结论

  • 严重先天性膈疝新生儿若临床指征明确应给予ECMO选项,度过术后初期者可获得持续生存获益。

研究设计与样本

  • 回顾性分析1989至2015年单中心Extracorporeal Life Support Organization登记表数据,共纳入98例需ECMO的先天性膈疝新生儿。

主要发现

  • 院内死亡率为32%,总死亡率为47.9%,死亡均发生在7个月内。
  • 术前、术中或术后使用ECMO的患者生存率无差异(P=0.65)。
  • 任何时间需血液滤过与生存率降低显著相关[风险比2.7(95%置信区间1.5-4.9);P=0.01]。
  • 出现神经系统并发症与生存率降低显著相关[风险比3.7(95%置信区间1.6-8.5);P=0.003]。
  • 年龄、Apgar评分、分娩方式、侧别、合并心脏疾病、pH、二氧化碳分压、氧分压、氧饱和度、碳酸氢盐、高频振荡通气、ECMO模式、吸入一氧化氮、肺部并发症及出血与生存差异无关。

临床怎么用

  • 对临床指征明确的严重先天性膈疝新生儿应考虑ECMO支持。
  • ECMO期间需血液滤过或出现神经系统并发症提示预后较差。

局限性

  • 单中心回顾性研究,样本量98例,长期费用与发病率未分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Neonates with severe congenital diaphragmatic hernia requiring extracorporeal membrane oxygenation (ECMO) have a high rate of mortality. There is controversy regarding optimal time of surgical intervention. We present our data over a 26-year period. METHODS: We analysed data from our Extracorporeal Life Support Organization registry forms between 1989 and 2015, in order to determine the factors affecting survival outcome for repair of congenital diaphragmatic hernia with ECMO as a bridge to surgery and/or recovery. RESULTS: Ninety-eight neonates with congenital diaphragmatic hernia requiring ECMO were identified. In-hospital mortality was 32%. The overall mortality (47.9%) in our study was seen up to 7 months, after this point there was no mortality. There was no difference in survival in patients repaired using pre-, intra- or postoperative ECMO (P = 0.65). Requiring haemofiltration at any point was significantly associated with reduced survival [hazard ratio 2.7 (95% confidence interval 1.5-4.9); P = 0.01] as was the presence of neurological complications [hazard ratio 3.7 (95% confidence interval 1.6-8.5); P = 0.003]. Age, Apgar score, mode of delivery, side, associated cardiac comorbidities, pH, partial pressure of carbon dioxide, partial pressure of oxygen, oxygen saturations, bicarbonate, high-frequency oscillatory ventilation, mode of ECMO, inhaled nitric oxide, pulmonary complications and bleeding were not associated with any survival difference. CONCLUSIONS: We believe that all neonates with severe diaphragmatic hernia should be given the option of ECMO if clinically indicated. Provided these patients survive the initial postoperative period, they go on to have a sustained survival benefit. Long-term cost analysis and morbidity need to be taken into account to determine the true effect of ECMO on congenital diaphragmatic hernia.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Vaja R, Bakr A, Sharkey A, et al. The use of extracorporeal membrane oxygenation in neonates with severe congenital diaphragmatic hernia: a 26-year experience from a tertiary centre. Eur J Cardiothorac Surg. 2017. PMID: 28475684. doi:10.1093/ejcts/ezx120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。